REPLIGEN CORPORATION

Repligen Corporation specializes in the design, manufacturing, and integration of advanced bioprocessing equipment, with a focus on tangential flow filtration (TFF) systems used in the purification and concentration of biological therapeutics. Their technical expertise centers on high-performance, GMP-compliant filtration platforms such as the KR2I BASE SYSTEM, which enable scalable, sterile processing of monoclonal antibodies, vaccines, and other non-diagnostic biological products. The company demonstrates deep proficiency in fluid handling systems, membrane technology, and process-scale chromatography interfaces, serving critical downstream purification workflows in biopharmaceutical development and production. Their systems are engineered for reproducibility, contamination control, and integration into closed, single-use manufacturing environments, positioning them as a precision supplier to mission-critical biomanufacturing operations. Repligen has delivered equipment solutions to both the Department of Health and Human Services and the Department of Defense, primarily supporting research and production efforts at federal biomedical laboratories. For HHS, they have provided TFF systems used in therapeutic development, while for the Defense Department, they have supplied identical platforms to the Walter Reed Army Institute of Research for defense-related biological product manufacturing—indicating a consistent role in supporting national biodefense and public health biomanufacturing initiatives. Their primary industry focus lies in Biological Product (Except Diagnostic) Manufacturing and Analytical Laboratory Instrument Manufacturing, where they bridge the gap between laboratory-scale research and commercial-scale bioprocessing. They serve the biopharmaceutical and government biomedical research sectors, specializing in process equipment that enables sterile, scalable, and regulatory-compliant production of advanced therapeutics. Repligen Corporation is a private entity headquartered in Waltham, Massachusetts, with no publicly disclosed government certifications. Their geographic and operational footprint is centered in the U.S. biotech corridor, aligning them with federal and commercial life science customers requiring precision bioprocessing hardware.